Match!
Christos Mikropoulos
Royal Surrey County Hospital
4Publications
2H-index
36Citations
Publications 3
Newest
Background Germline TP53 gene pathogenic variants (pv) cause a very high lifetime risk of developing cancer, almost 100% for women and 75% for men. In the UK, annual MRI breast screening is recommended for female TP53 pv carriers. The SIGNIFY study (Magnetic Resonance Imaging screening in Li Fraumeni syndrome: An exploratory whole body MRI) study reported outcomes of whole-body MRI (WB-MRI) in a cohort of 44 TP53 pv carriers and 44 matched population controls. The results supported the use of a ...
Source
#1Elena Castro (National Health Service)H-Index: 15
#2Christos Mikropoulos (National Health Service)H-Index: 2
Last.Rosalind A. Eeles (National Health Service)H-Index: 93
view all 20 authors...
Background. A better assessment of individualized prostate cancer (PrCa) risk is needed to improve screening. The use of the prostate-specific antigen (PSA) level for screening in the general population has limitations and is not currently advocated. Approximately 100 common single nucleotide polymorphisms (SNPs) have been identified that are associated with the risk of developing PrCa. The PROFILE pilot study explored the feasibility of using SNP profiling in men with a family history (FH) of P...
9 CitationsSource
#1Ed SaundersH-Index: 23
#2Tokhir DadaevH-Index: 13
Last.Zsofia Kote-JaraiH-Index: 43
view all 66 authors...
The HOXB13 gene has been implicated in prostate cancer (PrCa) susceptibility. We performed a high resolution fine-mapping analysis to comprehensively evaluate the association between common genetic variation across the HOXB genetic locus at 17q21 and PrCa risk. This involved genotyping 700 SNPs using a custom Illumina iSelect array (iCOGS) followed by imputation of 3195 SNPs in 20,440 PrCa cases and 21,469 controls in The PRACTICAL consortium. We identified a cluster of highly correlated common ...
26 CitationsSource
1